Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson
Argus Health
Daiichi Sankyo
Fish and Richardson

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for Patent: 3,937,838

« Back to Dashboard

Summary for Patent: 3,937,838

Title: Orally active bronchospasmolytic compounds and their preparation
Abstract:Novel compounds are disclosed having useful activity as bronchodilators of improved longevity of action and reduced incidence of side effects. These compounds are described by the formula: ##EQU1## wherein R.sub.1 is a member of the class consisting of tertiary butyl and cyclobutyl, and R.sub.2 is a hydrogen or 2 to 5 carbon atom acyl radical, and pharmaceutically acceptable salts thereof. The activity of these compounds is compared to previously known bronchodilators such as 1-(3', 5'-dihydroxyphenyl)-2-(isopropylamino)-ethanol, having the common name orciprenaline, and 1-(3', 4'-dihydroxyphenyl-2-isoproplyamino-ethanol, having the common name isoprenaline.
Inventor(s): Wetterlin; Kjell Ingvar Leopold (Sandby, SW), Svensson; Leif Ake (Lund, SW)
Assignee: Aktiebolaget Draco (Lund, SW)
Application Number:05/372,497
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;

No matches for this query

Foreign Priority and PCT Information for Patent: 3,937,838

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
14182/66Oct 19, 1966

International Patent Family for Patent: 3,937,838

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria286964► Subscribe
Austria287678► Subscribe
Austria287679► Subscribe
Austria288356► Subscribe
Belgium704932► Subscribe
Switzerland510625► Subscribe
Switzerland510626► Subscribe
Switzerland510627► Subscribe
Switzerland512428► Subscribe
Germany1643296► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Argus Health
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: